Cost Reduction

The Deady Group Sharpens Focus on Technology and Utility Procurement

The Deady Group Sharpens Focus on Technology and Utility Procurement

The Boston-based advisory firm refines its market focus on procurement, modernization, and recurring spend management, offering regulated and innovation-driven organizations potential cost reductions of 15-30%.

June 8, 2026
Liveops Launches On-Demand Call Center Model to Help Businesses Cut Overhead Costs

Liveops Launches On-Demand Call Center Model to Help Businesses Cut Overhead Costs

Liveops introduces a flexible outsourced call center model that allows businesses to scale customer support based on demand, reducing the financial burden of in-house teams.

May 29, 2026
Sydney SMEs Cut Overhead Costs by Over 30% Through Outsourced Payroll Services

Sydney SMEs Cut Overhead Costs by Over 30% Through Outsourced Payroll Services

Balance My Books' Q1 review reveals that Sydney small businesses using outsourced accounting and payroll services have reduced financial administration costs by more than 30% while gaining real-time financial visibility.

April 22, 2026
Businesses Turn to Cost-Reduction Strategies as Operational Expenses Continue to Rise

Businesses Turn to Cost-Reduction Strategies as Operational Expenses Continue to Rise

Savings Highway Global helps businesses identify significant savings opportunities across essential services like telecom, energy, and operational expenses amid challenging economic conditions.

October 20, 2025
Bollinger Innovations Slashes Cash Burn by 58% While Expanding Electric Vehicle Sales

Bollinger Innovations Slashes Cash Burn by 58% While Expanding Electric Vehicle Sales

Bollinger Innovations significantly reduced its quarterly cash burn from $21.2 million to $8.9 million while maintaining its electric vehicle manufacturing and sales capabilities across multiple commercial vehicle classes.

September 15, 2025
Indian Generic Cancer Drug Offers 98% Cost Reduction Compared to US Brand Name

Indian Generic Cancer Drug Offers 98% Cost Reduction Compared to US Brand Name

A critical development in cancer treatment accessibility shows Indian-manufactured generic Ibrutinib (Ibrunat) is available for as little as $250 per month, compared to $15,000 for the US brand-name Imbruvica, while offering the same therapeutic benefits for blood cancer patients.

February 4, 2025